-+ 0.00%
-+ 0.00%
-+ 0.00%

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee's warning has added a black-framed warning to limit Liteford's use in high-risk patients.

Zhitongcaijing·07/10/2026 10:17:17
Listen to the news
The European Medicines Agency's Pharmacovigilance Risk Assessment Committee's warning has added a black-framed warning to limit Liteford's use in high-risk patients.